Savara Inc
Stock Chart, Company Information, and Scan Results
$4.59(as of Nov 19, 3:58 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Savara Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$4.59
Ticker SymbolSVRA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees59
CountyUSA
Market Cap$848.5M
EBIDTA-120.4M
P/E Ratio-8.61
Forward P/E Ratio0.00
Earnings per Share-0.53
Profit Margin-Infinity%
RSI66.12
Shares Outstanding203.5M
ATR0.24
52-Week High4.86
Volume3,498,176
52-Week Low1.89
Book Value94.4M
P/B Ratio10.55
Upper Keltner4.77
P/S Ratio3,660.76
Lower Keltner3.67
Next Earnings DateUnknown
Cash Surplus-0.5M
Next Ex-Dividend DateUnknown
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Savara Inc In Our Stock Scanner
As of Nov 20, 2025
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.